Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00695747 · ClinicalTrials.gov registry record · NA

Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy

A NA study of Glaucoma and Cataracts, sponsored by Lahey Clinic.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT00695747: Completed NA study of Glaucoma and Cataracts, sponsored by Lahey Clinic.

NCT00695747 is a NA study of Glaucoma and Cataracts that has completed, run by Lahey Clinic. The registered enrollment target is 95 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00695747, a NA study of Glaucoma and Cataracts, has completed, sponsored by Lahey Clinic.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the safety \& effectiveness of the two types of cataract and glaucoma surgeries. Results from this study may improve the surgical and post surgical management and long term management of patients with these conditions in the future

Conditions Studied

Interventions

  • PROCEDURE 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy

Study Locations (1)

Massachusetts

  • Lahey Clinic, Inc. - Burlington

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 1998-01
Est. Completion 2009-01
Phase NA
Lahey Clinic

43 total trials

What the finished NCT00695747 record still lists

NCT00695747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy is the first listed.

NCT00695747 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00695747 about?

NCT00695747 is a clinical study titled "Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy". The purpose of this study is to compare the safety \& effectiveness of the two types of cataract and glaucoma surgeries. Results from this study may improve the surgical and post surgical management and long term management of patients with these conditions in the future

What is the current status of trial NCT00695747?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 1998-01. Estimated completion is 2009-01.

What conditions does trial NCT00695747 study?

This clinical trial studies the following conditions: Glaucoma, Cataracts.

What interventions are being tested in trial NCT00695747?

The interventions under investigation include: 2 Site procedure- Phacoemulsification/IOL and Trabeculectomy (PROCEDURE).

Who is sponsoring clinical trial NCT00695747?

This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00695747 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00695747's enrollment target sits among peer trials

95 46th of 92 higher than 47 of 92 other Glaucoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00695747, the US trial registry maintained by the National Library of Medicine. NCT00695747 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.